Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Br.Cu |
| Molecular Weight | 143.45 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu+].[Br-]
InChI
InChIKey=NKNDPYCGAZPOFS-UHFFFAOYSA-M
InChI=1S/BrH.Cu/h1H;/q;+1/p-1
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cuprous Sulfide (Cu2S) occurs in nature as the mineral and has very different two-dimensional lattice structures, along with excellent electro-catalysis and high conductivity. Recently published article has shown that nanocomposites incorporated with Cu2S nanoflowers can be used for skin tumor therapy and wound healing.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cu2S nanosheets for ultrashort pulse generation in the near-infrared region. | 2019-03-28 |
|
| Correction to Electrospun Micropatterned Nanocomposites Incorporated with Cu2S Nanoflowers for Skin Tumor Therapy and Wound Healing. | 2019-03-26 |
|
| Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. | 2010-12 |
|
| Copper binding affinity of S100A13, a key component of the FGF-1 nonclassical copper-dependent release complex. | 2006-09-01 |
|
| Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. | 2006-06-29 |
|
| Methionine regulates copper/hydrogen peroxide oxidation products of Abeta. | 2005-06 |
|
| Iron and gallium increase iron uptake from transferrin by human melanoma cells: further examination of the ferric ammonium citrate-activated iron uptake process. | 2001-04-30 |
|
| Human NAD(P)H:quinone oxidoreductase induction in human hepatoma cells after exposure to industrial acrylates, phenolics, and metals. | 1997-02 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:43:05 GMT 2025
by
admin
on
Mon Mar 31 21:43:05 GMT 2025
|
| Record UNII |
R8V209A5G0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID6052530
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | |||
|
m3919
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | Merck Index | ||
|
232-131-6
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | |||
|
7787-70-4
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | |||
|
270
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | |||
|
COPPER(I) BROMIDE
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | |||
|
R8V209A5G0
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY | |||
|
24593
Created by
admin on Mon Mar 31 21:43:05 GMT 2025 , Edited by admin on Mon Mar 31 21:43:05 GMT 2025
|
PRIMARY |